Logo image of ASG.CA

AURORA SPINE CORP (ASG.CA) Stock Fundamental Analysis

Canada - TSX-V:ASG - CA05206X1087 - Common Stock

0.29 CAD
0 (0%)
Last: 10/21/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ASG. ASG was compared to 16 industry peers in the Health Care Equipment & Supplies industry. The financial health of ASG is average, but there are quite some concerns on its profitability. ASG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ASG had negative earnings in the past year.
ASG had a positive operating cash flow in the past year.
In the past 5 years ASG always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ASG reported negative operating cash flow in multiple years.
ASG.CA Yearly Net Income VS EBIT VS OCF VS FCFASG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

ASG has a better Return On Assets (-9.77%) than 93.75% of its industry peers.
Looking at the Return On Equity, with a value of -28.62%, ASG belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
ROA -9.77%
ROE -28.62%
ROIC N/A
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
ASG.CA Yearly ROA, ROE, ROICASG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 59.64%, ASG is in line with its industry, outperforming 56.25% of the companies in the same industry.
ASG's Gross Margin has improved in the last couple of years.
ASG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
ASG.CA Yearly Profit, Operating, Gross MarginsASG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

5

2. Health

2.1 Basic Checks

ASG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ASG has been increased compared to 5 years ago.
ASG has a worse debt/assets ratio than last year.
ASG.CA Yearly Shares OutstandingASG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ASG.CA Yearly Total Debt VS Total AssetsASG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that ASG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ASG (0.21) is better than 81.25% of its industry peers.
The Debt to FCF ratio of ASG is 18.86, which is on the high side as it means it would take ASG, 18.86 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ASG (18.86) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that ASG is somewhat dependend on debt financing.
ASG has a Debt to Equity ratio (0.84) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 18.86
Altman-Z 0.21
ROIC/WACCN/A
WACC6.9%
ASG.CA Yearly LT Debt VS Equity VS FCFASG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

ASG has a Current Ratio of 2.03. This indicates that ASG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.03, ASG belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
ASG has a Quick Ratio of 1.13. This is a normal value and indicates that ASG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.13, ASG belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.13
ASG.CA Yearly Current Assets VS Current LiabilitesASG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for ASG have decreased strongly by -13.18% in the last year.
Looking at the last year, ASG shows a quite strong growth in Revenue. The Revenue has grown by 14.28% in the last year.
ASG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.51% yearly.
EPS 1Y (TTM)-13.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
Revenue 1Y (TTM)14.28%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASG.CA Yearly Revenue VS EstimatesASG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ASG.CA Yearly EPS VS EstimatesASG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ASG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASG.CA Price Earnings VS Forward Price EarningsASG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASG is valued cheaper than 87.50% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ASG is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 82.79
EV/EBITDA 62.99
ASG.CA Per share dataASG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SPINE CORP

TSX-V:ASG (10/21/2025, 7:00:00 PM)

0.29

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-20 2025-08-20
Earnings (Next)10-22 2025-10-22
Inst Owners0%
Inst Owner ChangeN/A
Ins Owners25.16%
Ins Owner ChangeN/A
Market Cap22.39M
Revenue(TTM)18.38M
Net Income(TTM)-1130100
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.87
P/FCF 82.79
P/OCF 22.16
P/B 4.04
P/tB 4.98
EV/EBITDA 62.99
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY1.21%
OCF(TTM)0.01
OCFY4.51%
SpS0.33
BVpS0.07
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.77%
ROE -28.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.64%
FCFM 1.05%
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
F-Score3
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 18.86
Debt/EBITDA 11.04
Cap/Depr 50.45%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion 238.59%
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.13
Altman-Z 0.21
F-Score3
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)69.84%
Cap/Depr(5y)82.94%
Cap/Sales(3y)4.27%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.28%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y124.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y355.27%
OCF growth 3YN/A
OCF growth 5Y319.03%